The purpose of this study is to determine whether organ sparing and target coverage can be simultaneously maintained for pencil beam scanning (PBS) proton therapy treatment of thoracic tumors in the presence of motion, stopping power uncertainties and patient setup variations. Ten consecutive patients that were previously treated with proton therapy to 66.6/1.8 Gy (RBE) using double scattering (DS) were replanned with PBS. Minimum and maximum intensity images from 4DCT were used to introduce flexible smearing in the determination of the beam specific PTV (BSPTV). Datasets from eight 2 / 20 4DCT phases, using ±3% uncertainty in stopping power, and ±3 mm uncertainty in patient setup in each direction were used to create 8×12×10=960 PBS plans for the evaluation of ten patients. Plans were normalized to provide identical coverage between DS and PBS. The average lung V20, V5, and mean doses were reduced from 29.0%, 35.0%, and 16.4 Gy with DS to 24.6%, 30.6%, and 14.1 Gy with PBS, respectively. The average heart V30 and V45 were reduced from 10.4% and 7.5% in DS to 8.1% and 5.4% for PBS, respectively. Furthermore, the maximum spinal cord, esophagus and heart dose were decreased from 37.1 Gy, 71.7 Gy and 69.2 Gy with DS to 31.3 Gy, 67.9 Gy and 64.6 Gy with PBS. The conformity index (CI), homogeneity index (HI), and global maximal dose were improved from 3.2, 0.08, 77.4 Gy with DS to 2.8, 0.04 and 72.1 Gy with PBS. All differences are statistically significant, with p values <0.05, with the exception of the heart V45 (p= 0.146).
Introduction
The variability and uncertainty in water equivalent thickness (WET) along the intended proton beam path within a patient can cause a target miss if not properly taken into account. Urie et al. proposed a correction strategy for the double scattering (DS) technique by minimizing compensator thickness over a smeared radius (i.e., the misaligned distance of the target), and extending the distal and proximal proton beam range by a percentage given by the uncertainty in converting CT Hounsfield units to stopping power. This "smearing" approach uses a perpendicular search radius, typically fixed at 5 mm, over the entire beam path to add treatment margin to the target along the beam path and was implemented in the treatment of thoracic tumors by Moyers Respiratory motion patterns change among different segments of the thorax region (Keall et al.) . The magnitude of motion at a patient's surface (i.e., at the beam entrance) can be significantly smaller than that of tumor motion (Liu et al. and Weiss et al.) . Therefore, a fixed smearing value based on the magnitude of target motion would typically be too large for proximal regions along the beam path, and a BSPTV using a fixed smearing radius corresponding to tumor motion magnitude would be larger than needed. Multiple researchers have attempted to refine the BSPTV method using 4DCT for PBS treatment. Graeff et al. attempted to extend BSPTV to multiple field optimization (MFO) IMPT fields in GSI's in-house TPS.
Knopf et al. calculated BSPTV as the union of multiple treatment targets (CTV + margins) over different phases of 4DCT
using the PSI and NIRS in-house deformable registration algorithms.
PBS treatment planning for thoracic tumors can achieve better sparing of organs at risk (OAR) than IMRT techniques (Chang et al., Kang et al. and Zhang et al.) . Despite the dosimetric advantages of PBS, DS and IMRT remain the methods of choice for treating complex thoracic tumors. This is primarily because commercial treatment planning systems (TPS) are unable to: (1) calculate proton spot delivery interplay with organ motion, which can lead to overdose and underdose within the treatment volume, and (2) determine appropriate treatment margins around the treatment target due to uncertainties of motion, stopping power and setup, which might result in partial anatomical miss or underdose of the target volume. Although Li et al. recently evaluated the systemic errors in 3D dose calculation that appear in the PBS treatment of thoracic tumors, there is no simultaneous comparisons of OAR sparing and plan robustness between PBS and DS treatments in this disease site (Wink et al.) In this work, we describe the development of a patient field-specific BSPTV, that incorporates respiratory motion and stopping power uncertainties using 4DCT for PBS treatment of thoracic tumors. As reported by previous researchers conceptualize the method of using the union of (multiple deformable targets + treatment margins) over different breathing 4 / 20 phases in two different in-house TPS of PSI and NIRS, our treatment margin is applied to average CT images and the iCTV, which is the union of multiple CTV targets rigidly registered from eight phases in a commercially available TPS (Varian Eclipse, Palo Alto, CA). Compared to Knopf and Graeff's approach, we need only to calculate WETM and convert WETM to GTM once instead of eight or ten times (the # of breathing phases). This may lead to slightly larger target volumes than those of Knopf and Graeff, similar to the more generous margin calculation method proposed by Flampouri et al. for DS treatment. To illustrate the potential advantages of BSPTV using 4DCT for the treatment of thoracic tumors, we will demonstrate how such a method is equivalent to "flexible smearing" in DS and can generate a more appropriate treatment target volume for a typical patient. The focus of this study is to establish a method of BSPTV calculation and organ interplay so that we can systemically report the dosimetric difference of PBS and DS treatment methods for ten thoracic tumor patients. Such methods and dosimetric studies can also serve as the platform and baseline for future improvements that can be brought by various motion mitigation strategies such as multiple beam paintings, gating and tracking techniques (Lomax et al.)
Methods
In conventional radiation therapy, the internal clinical target volume (iCTV) is delineated by a radiation oncologist and by the union of CTVs on the corresponding eight-or ten-phase images of a 4DCT on average CT images. To account for random and systematic errors of patient setup, an additional margin of 5-8 mm is used to expand an iCTV to a PTV.
Our methodology to calculate WETM and convert WETM to GTM is based on the phase and average images of 4DCT and implemented as a standalone MATLAB (MathWorks, MA) program. The generated BSPTV were imported into Eclipse TPS for subsequent optimization, thus providing better PBS treatment plan of thoracic tumors. Instead of using a "fixed smearing" distance to search for maximal WEPL change over a beam path, the maximal difference of WEPL between eight 4DCT phases and the average CT images was used as WETM along each beam path. The distal and proximal water equivalent margins (DM we and PM we ) due to organ motion (WETM) were calculated as the WEPL difference between the MIP, MinIP and average of the eight phases of the 4DCT, respectively (Equations 1 and 2). In this manner, different smearing radii along the beam path, i.e. "flexible smearing," were effectively used to calculate WETM. Such WETM were later implemented as additional voxels beyond treatment targets (i.e. GTM) based on the local Hounsfield units in the average CT images and the projected voxel size over the beam path, whose summation should equal to WEPL differences (Equations angle of 270 degree. Because the motion of the ribs is less than that of the target, a fixed smearing of 5 mm radius overestimates the distal and proximal BSPTV margins. For the regions close to the heart, however, the distal BSPTV margin from flexible smearing can be slightly larger than that from fixed smearing because cardiac motion can exceeds 5 mm. In addition, cardiac motion is not inadequately modeled by breathing-phase-based 4DCT images. Figure 1 
how the beam specific range uncertainties are broken down into three aspects: internal motion (Motion), stopping power ratio (SPR) of medium-to-water versus Hounsfield units in CT images, and the accuracy of image guidance (Setup). The BSPTV calculation uses 3% of the proton range plus 1 mm related to CT/stopping powers and, for patient setup variation, 2 mm along AP/RL directions and 3 mm along the SI direction. As these three sources of uncertainties are most likely independent, a quadratic method was primarily used for the summation of three uncertainties; however, a linear summation was also used to ensure target coverage, providing there was no overlap with adjacent organs at risk. (4) where i are the voxels along the beamlet from the patient surface to the proximal and distal surfaces of iCTV in Equation 1 6 / 20 and 2, respectively; j are the amount of voxels to be determined in the distal and proximal GTM regions in Equation 3 and 4, respectively; and where l and dl are voxels and projected voxel dimension along the beam path in average CT, respectively.
We further define two overlap volumes; one between the BSPTV and organs, and the other between the beam path outside of the BSPTV and organs. While the beam path overlap volume may receive less than the full prescription dose of 66.6 Gy, minimizing the overlapped volumes along with the BSPTV will allow for sparing of lung, heart and cord prior to the step of plan optimization. Figure 4 , with a breathing period of ~3.5 seconds and delivery durations of ~60 seconds and ~46 seconds for the two beams. Switching time between energy layers, slew duration between spots and spot duration of the same energy layer were extracted from the beam delivery log files. For different treatment fractions or beam paintings within the same fraction, the beams start from a random position in the 3.5-second breathing period. PBS spots were therefore grouped into the eight different breathing phases. A single treatment plan was therefore split into eight plans outside of Eclipse using our in-house Matlab programs and a Dicom editor provided by Ion Beam Applications (Louvain-La-Neuve, Belgium). These plans were subsequently reimported into Eclipse TPS to calculate the dose distribution of each CT phase.
The eight dose distributions were deformed and registered to the exhale-50 phase and summed in MIM Maestro (MIM Software Inc., Cleveland, OH).
Results
Table 1-(a) shows the magnitude of motion at three locations along the beam path for the ten consecutive patients evaluated. Tumor motion was larger than that of the ribs or at the patients' surface (beam entrance), and it was largest in the SI direction (~8 mm) followed by AP (~4 mm) and RL (~2 mm) directions. In contrast, the average motion of the ribs and patient surface at the beam entrance were less than 1.5 mm and 1 mm, respectively. Out of ten patients, all of whom were 8 / 20 treated with two-field plans, six plans were treated using posterior and posterior oblique beams only, two plans involve a lateral beam, and the other two plans included an anterior beam. With supine positioning, there is minimal motion of ribs and posterior beam entrance. In contrast, when lateral or anterior beams were used, the motion was larger. Table 1 In keeping with the dose constraints from RTOG 1308, only the maximum dose was constrained for esophagus.
Despite this, PBS still resulted in a reduction in the average volume of esophagus irradiated. A p value of 0.049 indicates that the D max for PBS can be larger than for DS for some patients, although this occurs only when D max is well below 74 Gy. (Table 2 and Figure 3 ) suggests that additional patients would benefit from PBS. Table 2 shows that the integral dose (ID) is reduced by nearly 17% in PBS compared with DS. Additionally, the irradiated volume of the prescription dose (CI) is only reduced by 10%. The target coverage quality CQ is identical between PBS and DS, as 99% of the iCTV was required to receive the prescription dose with both techniques. In contrast, PBS results in a significantly more homogenous dose, with a homogeneity index HI of 0.04 compared with 0.08 for DS. Except for the marginal advantage of CI (p = 0.056), all the differences above were highly statically significant, with p <0.01.
The robustness of iCTV coverage is shown in Fig. 3-(b) for all ten patients. For all PBS and DS plans, the iCTV receives no less than 97% of the prescription dose when all permutations of motion, CT/stopping power and patient setup uncertainties are included. Despite many clinical fears over overdose/underdose within the treatment target and target miss, it seems that PBS can potentially provide robust target coverage comparable or superior to that of DS when uncertainties are properly accounted for in the BSPTV with a repainting method to be discussed.
Discussion
Flampouri et al. proposed two methods to improve BSPTV in DS over the approach of Park et al by incorporating respiratory motion using two methods. The first uses MIP and MinIP data from 4DCT to determine the distal and proximal margins, respectively. In the second, the 4DCT phase that generates the largest margins is selected for each beamlet (beam path) to the target. The beamlet method results in a smaller BSPTV than the MIP/MinIP method. Unlike DS, however, in which all energy layers are delivered within 0.1 seconds, PBS delivers different energy layers sequentially over minutes.
Thus delivery of the distal and proximal layers are out of phase and, in contrast with DS, more generous margins must be determined from MIP/MinIP instead of the worst 4DCT phase in PBS. We demonstrated that the contribution from motion is the dominant effect over stopping power and setup uncertainties to the treatment margins in PBS and concluded that "flexible smearing" based on MIP/MinIP is crucial to the success of PBS plan optimization. We further included the overlapped volumes of beam path with organs. Unlike DS, which always over treats proximal organs, sparing of such OARs by PBS beam can be substantial.
Our finding that the iCTV is more homogenously covered in PBS than in DS does not account for organ interplay with beam delivery in PBS. Accounting for interplay, the target dose distribution in each of 37 fractions of PBS is more heterogeneous than the planned distribution. The breathing period of ~3.5 second is comparable with the switching time between energy layers (1-2 seconds for our PBS system) and also comparable with the time required to paint each energy layer (with 3-5 ms per spot and 2-4 ms slew duration between adjacent spots with a total of ~6000 spots over ~20 energy layers). Our study indicates that an energy layer can be delivered in 1-4 out of 8 different breathing CT phases of different breathing cycles. As our spot size is relatively small, more fractions might be needed to achieve total dose homogeneity compared with centers employing larger spot sizes. Figure 4 shows the interplay on an axial slice: underdose (95%) and overdose (110%) are present for a single fraction without any motion mitigation. As a worst case scenario, dose heterogeneities from 90-120% can occur in a single fraction. However, such a magnitude of overdose and underdose within the target will be reduced when more treatment fractions are used. With 4 fractions, the extent of such overdose drops to 105%, with no 95% underdose, and with 8 fractions the 105% overdose volume decreases even further. The summated distribution from the deformable registered dose distributions of four fractions accounting interplay has a slightly larger area of 105% isodose and slightly smaller minimal dose than the planned dose distribution. With eight fractions, there was no observable difference for the DVH of the iCTV that accounted for interplay and the original treatment plan without interplay.
As multiple beam paintings of 4 are clinically achievable, we believe that the dosimetric advantage of PBS treatment in this patient will be able to be maintained despite the interplay phenomenon. These observations are consistent with that reported by many researchers (Rietzel et the spot size incident on the patient is smaller than systems that use nozzle-mounted range shifters. Therefore, conclusions drawn from this study may not be applicable to other beam lines.
Conclusion
The use of a beam-specific PTV based on respiratory motion along the beam path derived from 4DCT and incorporating CT/stopping power and patient setup uncertainties can achieve better organ sparing with PBS compared to DS.
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Additionally, our study indicates that PBS planning based on BSPTV method can potentially achieve both better target homogeneity and robustness of target coverage using a repainting delivery method. Finally, beam angle optimization provides a reliable method to minimize doses to the critical organs. 

